[144] Penumbra, Inc. SEC Filing

Rhea-AI Filing Summary

Penumbra, Inc. filed a Form 144 notifying an intended sale of 372 common shares through Morgan Stanley Smith Barney LLC with an aggregate market value of $89,339.52. The filing lists 38,999,129 shares outstanding and an approximate sale date of 08/12/2025 on the NYSE. The 372 shares were acquired as restricted stock in two grants of 186 shares each, dated 03/31/2025 and 06/30/2025, with payment noted as Not Applicable. The filing reports Nothing to Report for securities sold in the past three months and includes the seller's representation that they do not possess undisclosed material adverse information, with reference to Rule 10b5-1 plan language.

Insights

Securities Analyst

TL;DR: Routine insider sale notice—372 shares ($89,339.52) scheduled for 08/12/2025; negligible market impact.

The Form 144 documents an intended sale of 372 common shares valued at $89,339.52 through Morgan Stanley Smith Barney LLC on the NYSE. Against the reported 38,999,129 shares outstanding, this position represents approximately 0.00095% of outstanding common shares, indicating the transaction is immaterial to supply or market liquidity. The filing also confirms no sales in the prior three months, which signals this is an isolated planned disposition of recently acquired restricted stock.

Corporate Governance Expert

TL;DR: Filing records disposition of restricted stock grants with standard seller certifications; governance implications are routine.

The notice shows two restricted stock grants of 186 shares each acquired on 03/31/2025 and 06/30/2025 and intended for sale in aggregate as reported. The signer asserts no undisclosed material adverse information and references Rule 10b5-1 plan adoption language, which are standard compliance representations on Form 144. There are no indications in the filing of unusual governance or disclosure issues.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	372	89339.52	38999129	08/12/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/31/2025	Restricted Stock	ISSUER			186	03/31/2025	Not Applicable
Common	06/30/2025	Restricted Stock	ISSUER			186	06/30/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Penumbra (PEN) Form 144 report?

The filing reports intent to sell 372 common shares through Morgan Stanley Smith Barney LLC with aggregate market value $89,339.52, approximate sale date 08/12/2025 on the NYSE.

How many Penumbra shares outstanding are listed in the filing?

The Form 144 lists 38,999,129 shares outstanding.

When were the shares being sold acquired?

They were acquired as restricted stock in two grants of 186 shares each on 03/31/2025 and 06/30/2025; payment is noted as Not Applicable.

Did the filer report any PEN securities sold in the past three months?

The filing states Nothing to Report for securities sold during the past three months.

Which broker and exchange are involved in the reported sale?

The broker is Morgan Stanley Smith Barney LLC and the filing lists the exchange as the NYSE.